{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T07:40:52Z","timestamp":1774165252553,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T00:00:00Z","timestamp":1208131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Women with <jats:italic>BRCA1<\/jats:italic> or <jats:italic>BRCA2<\/jats:italic> mutations have a substantially increased risk of breast and ovarian cancer compared with the general population. Therefore, prophylactic mastectomy (PM) and bilateral salpingo-oophorectomy (BSO) have been proposed as risk-reduction strategies for <jats:italic>BRCA1\/2<\/jats:italic> mutation carriers. We aimed to assess the feasibility of coordinated PM and BSO in hereditary breast-ovarian cancer syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>High risk women for breast and ovarian cancer who underwent coordinated PM and BSO were included in this study. Clinical characteristics and surgical and oncologic outcomes were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twelve patients underwent coordinated PM and BSO. Ten had history of previous breast cancer. Autologous breast reconstruction was performed in ten patients. The mean age at surgery was 43 (range 34\u201365). Mean operating time was 9.3 hours (range 3\u201316) with a mean postoperative hospitalization of 5.4 days (range 4\u20138). Intraoperatively, there were no major surgical complications. Postoperatively, one patient developed an abdominal wound dehiscence, another reoperation for flap congestion; one had umbilical superficial epidermolysis, and one patient developed aspiration pneumonia. At a mean follow-up of 84 months, 10 of patients were cancer-free. Although no patients developed a new primary cancer, two developed a distant recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Coordinated PM and BSO is a feasible procedure with acceptable morbidity in selected high-risk patients that desire to undergo surgery at one operative setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-101","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T06:14:24Z","timestamp":1208240064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome"],"prefix":"10.1186","volume":"8","author":[{"given":"Larissa I","family":"Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth K","family":"Beahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu K","family":"Arun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,14]]},"reference":[{"issue":"3","key":"1039_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998, 62 (3): 676-689. 10.1086\/301749.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1039_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72 (5): 1117-1130. 10.1086\/375033.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1039_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1399-0004.2006.00673.x","volume":"70","author":"KK Oros","year":"2006","unstructured":"Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN: Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and\/or ovarian cancer families of French Canadian descent. Clin Genet. 2006, 70 (4): 320-329. 10.1111\/j.1399-0004.2006.00673.x.","journal-title":"Clin Genet"},{"issue":"23","key":"1039_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006, 98 (23): 1694-1706.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"1039_CR5","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA: Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004, 22 (12): 2328-2335. 10.1200\/JCO.2004.04.033.","journal-title":"J Clin Oncol"},{"issue":"16","key":"1039_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","volume":"24","author":"LJ Pierce","year":"2006","unstructured":"Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs C, Merajver SD, Wong JS, Garber JE, Weber BL: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer. J Clin Oncol. 2006, 24 (16): 2437-2443. 10.1200\/JCO.2005.02.7888.","journal-title":"J Clin Oncol"},{"key":"1039_CR7","unstructured":"National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. Genetic\/familial high risk assessment: breast and ovarian. [http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf]"},{"issue":"9354","key":"1039_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","volume":"361","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P: Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003, 361 (9354): 296-300. 10.1016\/S0140-6736(03)12342-2.","journal-title":"Lancet"},{"issue":"9","key":"1039_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/ijc.21536","volume":"118","author":"J Gronwald","year":"2006","unstructured":"Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA: Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer. 2006, 118 (9): 2281-2284. 10.1002\/ijc.21536.","journal-title":"Int J Cancer"},{"issue":"21","key":"1039_CR10","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002, 346 (21): 1616-1622. 10.1056\/NEJMoa012158.","journal-title":"N Engl J Med"},{"issue":"21","key":"1039_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002, 346 (21): 1609-1615. 10.1056\/NEJMoa020119.","journal-title":"N Engl J Med"},{"issue":"6","key":"1039_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004, 22 (6): 1055-1062. 10.1200\/JCO.2004.04.188.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1039_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/GCO.0b013e32801195da","volume":"19","author":"SM Domchek","year":"2007","unstructured":"Domchek SM, Rebbeck TR: Prophylactic oophorectomy in women at increased cancer risk. Curr Opin Obstet Gynecol. 2007, 19 (1): 27-30.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"1039_CR14","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995, 56 (1): 265-271.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1039_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/jama.283.5.617","volume":"283","author":"D Schrag","year":"2000","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JC: Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. Jama. 2000, 283 (5): 617-624. 10.1001\/jama.283.5.617.","journal-title":"Jama"},{"issue":"1","key":"1039_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/01.sap.0000252487.27077.d6","volume":"59","author":"EI Chang","year":"2007","unstructured":"Chang EI, Ly DP, Wey PD: Comparison of aesthetic breast reconstruction after skin-sparing or conventional mastectomy in patients receiving preoperative radiation therapy. Ann Plast Surg. 2007, 59 (1): 78-81. 10.1097\/01.sap.0000252487.27077.d6.","journal-title":"Ann Plast Surg"},{"issue":"1","key":"1039_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cps.2006.11.013","volume":"34","author":"M Jugenburg","year":"2007","unstructured":"Jugenburg M, Disa JJ, Pusic AL, Cordeiro PG: Impact of radiotherapy on breast reconstruction. Clin Plast Surg. 2007, 34 (1): 29-37; abstract v-vi. 10.1016\/j.cps.2006.11.013.","journal-title":"Clin Plast Surg"},{"issue":"9","key":"1039_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/cncr.20617","volume":"101","author":"K Goldflam","year":"2004","unstructured":"Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F: Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004, 101 (9): 1977-1986. 10.1002\/cncr.20617.","journal-title":"Cancer"},{"issue":"7","key":"1039_CR19","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1097\/00006534-200006000-00010","volume":"105","author":"DW Chang","year":"2000","unstructured":"Chang DW, Reece GP, Wang B, Robb GL, Miller MJ, Evans GR, Langstein HN, Kroll SS: Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg. 2000, 105 (7): 2374-2380. 10.1097\/00006534-200006000-00010.","journal-title":"Plast Reconstr Surg"},{"issue":"3 Pt 1","key":"1039_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","volume":"108","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH: Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol. 2006, 108 (3 Pt 1): 515-520.","journal-title":"Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-101\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:01:10Z","timestamp":1630461670000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,14]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-101","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,14]]},"assertion":[{"value":"19 October 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"101"}}